Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

HonorHealth patient first in Arizona to receive new investigational treatment for ischemic stroke

A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new investigational treatment that targets platelets - rather than traditional clotting proteins - to help reopen blocked blood vessels in the brain.

20 Jan 2026

ELRIG announces Drs Stephen Ward and Annarita Miccio as keynote speakers for Cell and Gene Therapy 2026

ELRIG, a not-for-profit, volunteer-led organization dedicated to the global drug discovery community, today announced the keynote speakers for Cell and Gene Therapy 2026. Drs Stephen Ward (Cell and Gene Therapy Catapult) and Annarita Miccio (Imagine Institute) will lead the inaugural two-day event taking place at Hinxton Hall in Cambridge, UK from 9-10 March.

20 Jan 2026

Monolithic photocurable hyaluronic acid patch achieves strong wet adhesion for durotomy repair

Durotomy is a common neurosurgical complication involving a tear in the dura mater, the protective membrane surrounding the brain and spinal cord.

16 Jan 2026

Bio-engineered skin grafts offer new hope for severe burn injuries

Bio-engineered skin grafts can play an important role in the treatment of burn victims. Researchers at the University of Zurich have been working on new approaches for such grafts for over 15 years.

15 Jan 2026

One‑Step ADC Manufacturing Reaches 95% Yield in Under One Hour, BioDlink White Paper Reveals

A new white paper from BioDlink, From Complexity to Consistency: How CDMOs Can Unlock One-Step, High-Yield and Homogeneous ADC Manufacturing for Next-Gen Oncology, reveals an advancement in antibody-drug conjugate (ADC) manufacturing

From BioDlink 15 Jan 2026

UC San Diego project aims to bioprint patient-specific transplantable human livers

Liver failure is one of the most serious and deadly medical conditions, claiming thousands of lives each year as patients in the United States wait for a donor organ.

14 Jan 2026

Axol Bioscience raises $2.8 M to advance US expansion and product development

Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, today announced that it has secured $2.8 million (£2.1 million) in funding.

13 Jan 2026

Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial.

13 Jan 2026

New test could improve future diagnosis and monitoring of IBD

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests.

13 Jan 2026

Study shows biosynthetic method to make low-calorie sugar substitute

From saccharin in the 19th century to stevia and monk fruit in the 21st, researchers and the food industry have long sought a sweetener that delivers the taste of sugar without its drawbacks-excess calories, tooth decay, and heightened risk for obesity, insulin resistance, and diabetes.

12 Jan 2026

New technology enables cuffless non-invasive blood pressure monitoring

12 Jan 2026

One Health action needed as environmental reservoirs fuel drug-resistant infections

Environmental antimicrobial resistance is turning rivers, soils, and even the air into hidden highways for "superbugs," according to a new review that calls for urgent, coordinated action across human, animal, and environmental health.

9 Jan 2026

UBC researchers crack code to grow helper t cells from stem cells

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell-known as helper T cells-from stem cells in a controlled laboratory setting.

8 Jan 2026

CIRM awards $7.4 million to advance stem cell-based gene therapy for Friedreich's ataxia

The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for Friedreich's ataxia, a rare inherited neurodegenerative disease that causes progressive loss of coordination, muscle strength, heart function and overall mobility.

8 Jan 2026

Recent advances in CAR-NK cell therapy could revolutionze cancer treatment

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, manufacturing complexity, and limited effectiveness against solid tumors.

8 Jan 2026

Flexible ultrasonic sensor offers accurate, cuff-free blood pressure readings

A new technology has been developed that enables cuffless non-invasive blood pressure monitoring by using ultrasonic to track real-time changes in vascular diameter-without the need for a traditional cuff. The technology is expected to serve as a core component in future wearable healthcare devices and smart medical monitoring platforms.

8 Jan 2026

Reprogramming immunity to protect beta cells in type 1 diabetes

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the leading global T1D research and advocacy organization, Leonardo Ferreira, Ph.D., assistant professor of Pharmacology and Immunology, and his collaborators at partnering institutions will explore a new approach to treating – and potentially curing – the disease.

7 Jan 2026

FUJIFILM Irvine Scientific now officially FUJIFILM Biosciences

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the life science market, today announced the Company has officially changed its legal name from FUJIFILM Irvine Scientific, Inc., to FUJIFILM Biosciences Inc., effective January 1, 2026.

5 Jan 2026

Silica nanomatrix enhances immunotherapy for solid tumors

Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of all disease-related deaths in the city in 2025. While chemotherapy remains a major treatment modality, its side effects and the risk of relapse challenges for patients.

30 Dec 2025

Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and Alphazyme LLC (Alphazyme), a Maravai LifeSciences company specializing in enzymes for molecular biology, have executed a licensing agreement for a proprietary Optimer® binder developed for hot-start polymerase chain reaction (PCR) applications.

From Aptamer Group 24 Dec 2025

Manufacturing News and Research

Further Reading

HonorHealth patient first in Arizona to receive new investigational treatment for ischemic stroke

ELRIG announces Drs Stephen Ward and Annarita Miccio as keynote speakers for Cell and Gene Therapy 2026

Monolithic photocurable hyaluronic acid patch achieves strong wet adhesion for durotomy repair

Bio-engineered skin grafts offer new hope for severe burn injuries

One‑Step ADC Manufacturing Reaches 95% Yield in Under One Hour, BioDlink White Paper Reveals

UC San Diego project aims to bioprint patient-specific transplantable human livers

Axol Bioscience raises $2.8 M to advance US expansion and product development

Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial

New test could improve future diagnosis and monitoring of IBD

Study shows biosynthetic method to make low-calorie sugar substitute

New technology enables cuffless non-invasive blood pressure monitoring

One Health action needed as environmental reservoirs fuel drug-resistant infections

UBC researchers crack code to grow helper t cells from stem cells

CIRM awards $7.4 million to advance stem cell-based gene therapy for Friedreich's ataxia

Recent advances in CAR-NK cell therapy could revolutionze cancer treatment

Flexible ultrasonic sensor offers accurate, cuff-free blood pressure readings

Reprogramming immunity to protect beta cells in type 1 diabetes

FUJIFILM Irvine Scientific now officially FUJIFILM Biosciences

Silica nanomatrix enhances immunotherapy for solid tumors

Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®